chr5-143278591-C-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_000176.3(NR3C1):c.*3298G>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.476 in 151,876 control chromosomes in the GnomAD database, including 17,727 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.48 ( 17725 hom., cov: 31)
Exomes 𝑓: 0.42 ( 2 hom. )
Consequence
NR3C1
NM_000176.3 3_prime_UTR
NM_000176.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.125
Genes affected
NR3C1 (HGNC:7978): (nuclear receptor subfamily 3 group C member 1) This gene encodes glucocorticoid receptor, which can function both as a transcription factor that binds to glucocorticoid response elements in the promoters of glucocorticoid responsive genes to activate their transcription, and as a regulator of other transcription factors. This receptor is typically found in the cytoplasm, but upon ligand binding, is transported into the nucleus. It is involved in inflammatory responses, cellular proliferation, and differentiation in target tissues. Mutations in this gene are associated with generalized glucocorticoid resistance. Alternative splicing of this gene results in transcript variants encoding either the same or different isoforms. Additional isoforms resulting from the use of alternate in-frame translation initiation sites have also been described, and shown to be functional, displaying diverse cytoplasm-to-nucleus trafficking patterns and distinct transcriptional activities (PMID:15866175). [provided by RefSeq, Feb 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 5-143278591-C-A is Benign according to our data. Variant chr5-143278591-C-A is described in ClinVar as [Benign]. Clinvar id is 351321.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.533 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NR3C1 | NM_000176.3 | c.*3298G>T | 3_prime_UTR_variant | 9/9 | ENST00000394464.7 | NP_000167.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NR3C1 | ENST00000394464.7 | c.*3298G>T | 3_prime_UTR_variant | 9/9 | 1 | NM_000176.3 | ENSP00000377977 | A1 | ||
NR3C1 | ENST00000415690.6 | c.*773G>T | 3_prime_UTR_variant | 9/9 | 1 | ENSP00000387672 | ||||
NR3C1 | ENST00000343796.6 | c.*3298G>T | 3_prime_UTR_variant | 9/9 | 5 | ENSP00000343205 | A1 |
Frequencies
GnomAD3 genomes AF: 0.476 AC: 72184AN: 151732Hom.: 17710 Cov.: 31
GnomAD3 genomes
AF:
AC:
72184
AN:
151732
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.417 AC: 10AN: 24Hom.: 2 Cov.: 0 AF XY: 0.400 AC XY: 8AN XY: 20
GnomAD4 exome
AF:
AC:
10
AN:
24
Hom.:
Cov.:
0
AF XY:
AC XY:
8
AN XY:
20
Gnomad4 AFR exome
AF:
Gnomad4 NFE exome
AF:
GnomAD4 genome AF: 0.476 AC: 72238AN: 151852Hom.: 17725 Cov.: 31 AF XY: 0.469 AC XY: 34780AN XY: 74208
GnomAD4 genome
AF:
AC:
72238
AN:
151852
Hom.:
Cov.:
31
AF XY:
AC XY:
34780
AN XY:
74208
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Glucocorticoid resistance Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at